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We have investigated the mechanism of the changes in the profile of metabolic enzyme expression that occur in association with fast-to-slow
transformation of rabbit skeletal muscle. The hypotheses assessed are: do 1) lowered intracellular ATP concentration or 2) reduction of the
muscular glycogen stores act as triggers of metabolic transformation? We find that 3 days of decreased cytosolic ATP content have no impact on
the investigated metabolic markers, whereas incubation of the cells with little or no glucose leads to decreases in glycogen in conjunction with
decreases in glyceraldehyde-3-phosphate dehydrogenase (GAPDH) promoter activity, GAPDH mRNA and specific GAPDH enzyme activity
(indicators of the anaerobic glycolytic pathway), and furthermore to increases in mitochondrial acetoacetyl-CoA thiolase (MAT, also known as
ACAT) promoter activity, peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) expression and citrate synthase (CS) specific
enzyme activity (all indicators of oxidative metabolic pathways). The AMP-activated protein kinase (AMPK) activity under these conditions is
reduced compared to controls. In experiments with two inhibitors of glycogen degradation we show that the observed metabolic transformation
caused by low glucose takes place even if intracellular glycogen content is high. These findings for the first time provide evidence that metabolic
adaptation of skeletal muscle cells from rabbit in primary culture can be induced not only by elevation of intracellular calcium concentration or by
a rise of AMPK activity, but also by reduction of glucose supply. Contrary to expectations, neither an increase in phospho-AMPK nor a reduction
of muscular glycogen content are crucial events in the glucose-dependent induction of metabolic transformation in the muscle cell culture system
studied.
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dependent gene regulation1. Introduction
Skeletal muscle fibers are classified as “slow-oxidative” type
I fibers or as “fast” type II fibers with several metabolically
distinct subtypes. Type I fibers contract slowly, are rich in
mitochondria and use mainly oxidative metabolism for energy
production, whereas type IId/x fibers contract rapidly and rely⁎ Corresponding author. Tel.: +49 511 532 4800; fax: +49 511 532 2938.
E-mail address: Hanke.Nina@MH-Hannover.de (N. Hanke).
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doi:10.1016/j.bbamcr.2007.12.012on anaerobic metabolism for ATP production. Adult skeletal
muscle fibers show plasticity, which means they can alter their
fiber type to adapt to different physiological demands. Fiber
type transformation comprises a multitude of cellular changes
encompassing protein isoforms of contractile proteins, ion
channels and metabolic enzyme expression [1–4].
Our group established a primary culture of skeletal muscle
cells from rabbits growing on microcarriers, which develop the
adult pattern of fast myosin light and heavy chains in combi-
nation with a predominance of enzymes of anaerobic-glycolytic
metabolism [5], i.e. a fast-type adult muscle cell culture. When
treated with calcium ionophore A23187 to raise the intracellular
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and these myotubes show slow type I myosin light and heavy
chain expression as well as expression of elevated levels of
citrate synthase (CS) and reduced levels of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) and lactate dehydrogenase
(LDH) [5,6]. It was further established in experiments using the
calcineurin inhibitor cyclosporin A, that the Ca2+-induced
upregulation of slow myosin heavy chain I expression is
transduced by the calcium-calcineurin-NFAT-(nuclear factor of
activated T-cells) signalling pathway, while the alterations in
metabolic enzyme expression under calcium ionophore treat-
ment could not be suppressed by calcineurin inhibition [7].
Apart from calcium ionophore treatment, the switch from fast
to slow myosin heavy chain expression can also be induced by
the sequences of intracellular calcium transients that are asso-
ciated with repetitive electrostimulation of the adult myotubes
(cycles of 1 Hz for 15 min followed by 30 min pause). However,
in contrast to chronic electrostimulation in vivo, even stimula-
tion with this pattern at an increased frequency of 5 Hz had no
impact on the measured metabolic enzymes [8,9]. Searching for
differential effects of ionophore treatment and electrostimulation
with regard to metabolic adaptation, we found that calcium
ionophore treatment leads, in addition to highly elevated cyto-
plasmic calcium levels, to a strong reduction in glycogen content
of the myotubes, whereas electrostimulation in the above pattern
with intermittent pauses does not (Hanke, N. and Kubis, H.P.,
unpublished data). These observations and the fact that cal-
cineurin inhibition did not prevent metabolic transformation
during calcium ionophore treatment show that fast-to-slow trans-
formation of skeletal muscle is a process in which several sig-
nalling pathways are involved, such that transformation on the
level of contractile proteins can dissociate from transformation on
the level of metabolic enzymes. To assess the mechanisms res-
ponsible for metabolic transformation, we formulated two alter-
native hypotheses on the basis of the observations just described:
1. Calcium ionophore treatment and the associated increase of
intracellular calciumconcentration cause glycogen degradation
directly via Ca2+-dependent activation of glycogen phospho-
rylase by phosphorylase kinase and indirectly as a consequence
of extensive energy expenditure for SR calcium uptake and
elimination of Ca2+ from the cytosol via the sarcolemma. This
energy consumption could lead to a decreased ATP- and an
increased AMP-concentration and thereby to activation of the
AMP-activated protein kinase (AMPK). AMPK activation is
thought to be responsible for upregulation of mitochondrial
enzymes [10–14] and might be the mediator of the alterations
in CS, GAPDH and LDH expression seen in the muscle cell
culture during calcium ionophore treatment.
2. Low muscle glycogen content itself has been demonstrated
to enhance the transcription of a number of genes involved in
metabolic adaptation to exercise [15–17] and might be a
signal for the need of metabolic transformation. One obvious
possibility for the sensing of lowered glycogen content is the
release of signalling molecules like kinases, phosphatases or
transcription factors with glycogen binding domains or scaf-
fold proteins in the course of glycogen breakdown. The ex-istence of glycogen-binding scaffold proteins or subunits is
established for protein phosphatase 1 and AMPK [18–20].
The release of such glycogen-related signalling proteins could
participate in the initiation of the metabolic adaptations seen
under calcium ionophore treatment.
To test the first hypothesis, we performed experiments in
whichwe reduced the intracellular ATP concentration of the adult
myotubes by treatment with the creatine analogue 3-guanidino-
propionic acid (GPA). To test the second hypothesis, we de-
creased the glycogen content of the myotubes by incubation in
cell culture medium with reduced or no glucose. After 3 days of
GPA treatment or lowered glucose supply we looked for changes
inmarkers of oxidative and glycolytic metabolism to evaluate the
importance of intracellular ATP concentration and glycogen
content for the induction of metabolic adaptation.
2. Materials and methods
2.1. Animals
Animal experiments were carried out according to the guidelines of the local
Animal Care Commitee (Bezirksregierung Hannover).
2.2. Primary cell culture
Skeletal muscle cells from hindlimbs of newbornWhite New Zealand rabbits
were isolated and separated from fibroblasts as described previously [5]. Myo-
blasts were then diluted to a final density of 6.5×105 cells ml−1 in DMEM
(5.55mMglucose, Invitrogen, Karlsruhe, Germany) with 10%NCS (Invitrogen).
A volume of 15 ml of the cell suspension was poured into a 260 ml culture flask
together with 0.04 g microcarriers (CultiSpher-GL; Percell Biolytica, Astorp,
Sweden). Cells were grown at 37 °C with 8% CO2 and 95% humidity while
gently shaken to improve O2 supply to the cells. After 24 h the medium was
changed to 30 ml of Skeletal Muscle Growth Medium with 5% FCS and sup-
plements (PromoCell, Heidelberg, Germany). On day 6, the mediumwas changed
to DMEM with 10% rabbit serum (Invitrogen). On day 8, the medium was
changed to DMEMwith 5%NCS. Half of the mediumwas replaced every second
day. After 14 days in culture, addition of 5 mM 3-guanidinopropionic acid (GPA,
Sigma, München, Germany), 0.4 µM calcium ionophore A23187 (Sigma) or
treatment with DMEM without glucose (Invitrogen), supplemented with 1 mM
lactate and 5% NCS was continued for 3 days. Whenever inhibitors of glycogen
degradation 1,4-dideoxy-1,4-D-arabinitol (DAB, Novo Nordisk, Bagsvaerd, Den-
mark) or N-Butyldeoxynojirimycin (BDN, Calbiochem/Merck, Darmstadt, Ger-
many) were used, the cells were preincubated overnight with DAB or BDN before
the treatment with DMEM without glucose started.
2.3. RNA isolation and RT-PCR
For isolation of total RNA, cells on microcarriers were washed with PBS,
coveredwith RNA-Later (Ambion, Darmstadt, Germany) and stored at−20 °C as
recommended. RNA-isolation was carried out with the RNeasy Kit (Qiagen,
Hilden, Germany) including digestion of genomic DNA. Then cDNAwas syn-
thesized from 1.5 µg of total RNA using Omniscript Reverse Transcriptase
(Qiagen) as instructed. Semiquantitative multiplex PCRwas performed using the
HotStarTaq DNA Polymerase Kit (Qiagen), primers for the cDNA of interest and
the QuantumRNA 18 S Internal Standards Kit (Ambion) for normalisation. The
PCR program consisted of cycles of 95 °C for 1 min followed by 60 °C for 1 min
and 72 °C for 1 min, after an initial activation of the HotStarTaq at 95 °C for
15min. For every new set of samples, including controls, the exponential range of
PCR amplification and the appropriate ratio of 18S primers to 18S competimers
was determined in a preliminary experiment. PCR amplification of GAPDH
cDNAwas performed using 26 or 27 cycles, amplification of PGC-1α cDNAwas
performed using 33–35 cycles. The PCR primers used were as follows: GAPDH
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GTG C-3′, reverse primer: 5′-GCC TCT CGT CCT CCT CTG-3′ and PGC-1α
(GenBank accession no. AB025784) forward primer: 5′-CAA ACT TGC TAG
CGG TCC TC-3′, reverse primer: 5′-GTG TGG TTT GCATGG TTC TG-3′.
PCR products were separated in an 8%T, 5%C PAGE, using LowDNAMass
Ladder (Invitrogen) as a marker, followed by highly sensitive silver staining [21].
Densitometric quantification of target cDNA and 18S cDNA bands was per-
formed with an Image Master System (Pharmacia Biotech, Freiburg, Germany).
2.4. Analysis of enzyme activities
TheCS enzyme activitieswere analysed photometrically as has been described
[22]. Briefly, the reaction mixture pH 8.0 contained 100 µM Tris–EDTA, 5 µM
NAD+, 6 µM malate, 60 µg/ml malate dehydrogenase, 50 µl of sample and
0.22 µM acetyl-coenzyme A. ΔE(340 nm)/t was measured at 30 °C.
The GAPDH assay was performed in triethanolamine buffered solution pH
7,6 containing 82.5 mM triethanolamine, 6 mM glycerate-3-phosphate, 1.7 mM
MgSO4, 1.1 mM ATP, 0.9 mM EDTA, 0.2 mM NADH, 14.8 kU/l PGK and
sample, which had been stabilized by 5 mM DTT. ΔE(340 nm)/t was measured
at 30 °C.
Enzyme activities were normalised to total protein concentration of cell
homogenates, determined by the method of Oyama and Eagle [23] with bovine
serum albumin as a standard.
2.5. Measurement of intracellular ATP concentration
Intracellular ATP concentrations were measured with the ATP Determination
Kit (Molecular Probes, Karlsruhe, Germany). Briefly, muscle cells were lysed
and protein was denatured with 1.66M perchloric acid, then lysates were cleared
by centrifugation at 16000 ×g. Cleared lysates were buffered with bicine, titrated
(pH 7.8) and centrifuged again, then 10 µl of supernatant were used in a luciferase
assay using a Lumat Luminometer (Berthold Technologies, Nordstemmen,
Germany). The luciferase assay reagent was composed of 25 mM tricine, 5 mM
MgSO4, 1 mM dithiothritol, 0.1 mM EDTA, 0.5 mM D-luciferin and 1.25 µg/ml
firefly-luciferase. ATP concentrations were calculated with the help of a standard
curve and normalised to the protein concentrations of the samples.
2.6. Analysis of glycogen content
For analysis of glycogen content, muscle cell homogenates were treated with
0.4 M KOH at 100 °C, for destruction of intracellular free glucose and denatu-
ration of cell protein. This was followed by enzymatic hydrolysation of glycogen
and analysis of free glucose from glycogen as described [24]. For determination
of the free glucose concentration, absorbance of an assay containing 200 mM
Tris, 3 mMATP, 2 mMMgCl2, 0.33 mMNADP
+, 0.9 U/ml glucose-6-phosphate
dehydrogenase and 0.7 U/ml hexokinase is read at 340 nm. Free glucose from
glycogen concentrations were normalised to total protein concentrations of cell
homogenates.
2.7. Plasmid construction
A2257 bp rat GAPDHpromoter fragment (GenBank accession no.AB047300)
was generated from rattus norvegicus genomic DNA by high-fidelity long range
PCR (GeneAmp XL PCR Kit, Perkin Elmer Applied Biosystems, Waltham, MA,
USA) using specific primers (forward primer: 5′-CGTGGATCCTAAGCTCTG
CTC TGA GGA CAT G-3′, reverse primer: 5′-CTG AAG CTT TAT GAG ACG
AGG CTG GCA CTG-3′). The promoter fragment was cloned into the luciferase
reporter gene vector pXP2-luc [25]. An 892 bp promoter fragment of human
mitochondrial acetoacetyl-CoA thiolase (MAT; EC 2.3.1.9) [26] was also gene-
rated by PCR (forward primer: 5′-ACG TGG ATC CGA ATT CAG ACA GCA
TGG TGG-3′, reverse primer: 5′-CTG AAG CTT TAT GAG ACG AGG CTG
GCA CTG-3′) and cloned into pXP2-luc.
2.8. Cell culture transfections
Mouse C2C12 myoblasts (American Type Culture Collection, Wesel, Ger-
many) were cultured on petri dishes in growth medium (GM), consisting ofcomplete DMEM containing 25 mM glucose (Invitrogen) supplemented with
10% fetal calf serum (FCS, Biochrom, Berlin, Germany). Cells were transfected
at 50–60% confluency with 1.5 μg of promoter DNA, 0.35 μg of pCMV-Gal
and 2.5 μl/μg DNA of Lipofectamine 2000 Transfection Reagent (Invitrogen).
The transfection medium was removed after 5 h and replaced with GM. After
further 24 h, GM was replaced by differentiation medium (DM, DMEM con-
taining 25 mM glucose plus 5% horse serum (Biochrom)) and myotubes were
harvested 3 days after transfection.
In some experiments, cells were treated 24 h post-transfection with 0.1 μM
of calcium ionophore A23187 (Sigma) for 2 days. In other experiments, GMwas
replaced by DM containing 5.5 mM glucose (low glucose condition) and cells
were harvested for luciferase assays after additional 2 days of culture.
2.9. Promoter activity assays
Cells were lysed in 400 μl 1× Reporter Lysis Buffer (Promega, Mannheim,
Germany). 20 μl of lysate were used in a luciferase assay using a Lumat
Luminometer (Berthold Technologies) measuring relative light units (RLU).
The luciferase assay reagent was composed of 200 mM tricine, 10.7 mM
(MgCO3)4Mg(OH)2, 26.7 mM MgSO4, 333 mM dithiothritol, 5.3 mM ATP,
2.74 mM coenzyme A and 470 μM D-luciferin (Applichem, Darmstadt, Ger-
many). Cells were cotransfected with pCMV-Gal as an internal reference. The
ß-galactosidase activity (ß-Gal) was estimated in a standard assay [27].
2.10. Western blotting
Skeletal muscle cells grown on microcarriers were washed with PBS, fol-
lowed by lysis and denaturation with SDS-PAGE sample buffer at 95 °C for 3 min
followed by cooling on ice [28]. Samples were cleared by centrifugation at
18,000 ×g in Qia-Shredder Columns (Qiagen). Eluates were frozen and kept at
−80 °C until use. Equal amounts of total protein per lane were separated elec-
trophoretically in a 12% SDS-PAGE and then transferred to a nitrocellulose
membrane. After blocking in PBS containing 0.2% Tween and 5% low fat dry
milk for 45 min, blots were incubated overnight with primary antibodies at a
dilution of 1:1000 in blocking solution.We employedAMPK-antibodyA1475-03
from USBiological (Swampscott, MA, USA) and phospho-AMPKα-(Thr172)-
antibody no. 2531, Akt-antibody no. 9272, phospho-Akt-(Thr308)-antibody no.
9275, GSK-3β-antibody no. 9332 and phospho-GSK-3β-(Ser9)-antibody no.
9336 from Cell Signaling Technology (Danvers, MA, USA). Incubation with
primary antibody solution was followed by washing of the membrane in PBS-
Tween (3×10 min) and incubation with anti-rabbit horseradish peroxidase-linked
secondary antibody NA934 (Amersham Biosciences, Piscataway, NJ, USA) at a
dilution of 1:5000 in blocking solution for 1 h. After washing of the membrane in
PBS-Tween (3×10min), enhanced chemoluminescence detectionwas carried out
using the SuperSignal West Pico ECL Kit (Pierce, Rockford, IL, USA). Densi-
tometric quantification was performed with an Image Master System (Pharmacia
Biotech).
2.11. Statistics
Results are expressed as means±SD of three or more independent experi-
ments. The statistical significance of differences of these means was estimated by
one-way ANOVA followed by the Newman–Keuls multiple comparison test,
performed usingGraphPad Prism software version 3.00. Using theKolmogorov–
Smirnov test we found that the present data were compatible with a Gaussian
distribution. In case duplicates/triplicates were measured, the single values were
averaged before being entered into the statistical treatment and each of these
averages was taken as n=1.
3. Results
We hypothesised that in addition to the known Ca2+-
dependent metabolic adaptation of skeletal muscle cells, in
terms of upregulation of mitochondrial enzymes involved in
oxidative metabolism and downregulation of glycolytic
enzymes, metabolic changes might be induced 1) by activation
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lowered intracellular ATP levels or 2) by detachment of
signalling molecules during glycogen breakdown. To test these
hypotheses we used primary cultures of skeletal muscle cells
from rabbits, which develop the adult fast fiber type after 14 days
in culture on microcarriers [5].
3.1. No changes of metabolic markers after decreasing
intracellular ATP concentration
To test the first hypothesis, differentiated adult fast type
myotubes were treated with 3-guanidinopropionic acid (GPA)
to reduce the intracellular ATP concentration. GPA is a creatine
analogue that depletes high-energy phosphate compounds,
including phosphocreatine and ATP, from skeletal muscle.
Thus the intracellular ATP concentration in GPA treated muscle
cells is reduced and the concentration of ADP is increased. This
increase in ADP concentration leads to elevated levels of AMP
due to the activity of members of the adenylate kinase family.
The increased AMP concentration activates AMPK allosteri-
cally as well as via AMPK kinase (AMPKK) [29].
Incubation with 5 mMGPA for 20 h significantly reduces the
intracellular ATP concentration to approximately 70% of theFig. 1. Treatment of adult myotubes with 3-guanidinopropionic acid (GPA) for
20 h (A) or 3 days (B) results in reduction of the intracellular ATP concentration.
Shown are relative values in % of controls as means±SD of 3–4 experiments.
⁎ = significantly different from cells in medium without GPA, pb0.05.
Fig. 2. Enzyme activities of GAPDH (A) and CS (B) after 3 days of GPA
treatment of adult myotubes in culture. Shown are relative values in % of
controls as means±SD of 6 experiments. No statistical differences found.level in untreated control myotubes (Fig. 1A). Prolonged treat-
ment with 5 mM GPA for 3 days results in reduction of the
intracellular ATP concentration to 50% of controls (Fig. 1B).
After 3 days of treatment with 5 mM GPAwe measured the
enzyme activity of glyceraldehyde-3-phosphate-dehydrogenase
(GAPDH) as a marker of glycolytic capacity and the enzyme
activity of citrate synthase (CS) as an indicator of mitochondrial
mass and function [30]. Reduction of the intracellular ATP
concentration to about 50% of control levels showed no effect on
GAPDH and CS enzyme activities (Fig. 2A and B) nor on
mRNA levels of GAPDH, fumarase, or peroxisome proliferator-
activated receptor γ coactivator 1α (PGC-1α) (data not shown).
3.2. DMEM without glucose induces metabolic adaptation of
skeletal muscle cells in culture
To test the second hypothesis, we incubated adult myotubes
for 3 days in DMEM with 5.55 mM glucose (controls) or in
glucose-free DMEM to reduce the intracellular glycogen con-
tent. This results in a glycogen depletion to about 40% of control
levels, whereas 3 days of calcium ionophore A23187 treatment
in DMEM with 5.55 mM glucose reduce the intracellular gly-
cogen stores only to approx. 60% of the glycogen content of
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calcium ionophores to get data compatible with previous expe-
riments on fast-to-slow transformation [5–7]. C2C12 myotubes
showed reductions in glycogen content similar to those seen in
adult rabbit myotubes in primary culture when treated with
DMEM with lowered glucose or A23187 (Fig. 3B).
To assess the impact of lowered glycogen content on the
profile of metabolic enzymes we measured GAPDH and CS
enzyme activities, the relative mRNA levels of GAPDH and
PGC-1α by semiquantitative RT-PCR (all these quantities in
rabbit muscle primary cultures), and in addition we determined
promoter activities of GAPDH and mitochondrial acetoacetyl-
CoA thiolase (MAT) in mouse C2C12 muscle cells by luciferase
assay. We chose PGC-1α as a marker of mitochondrial bio-Fig. 3. (A) Glycogen content of adult myotubes cultivated for 3 days in DMEM
without glucose (−Glu.) or in DMEM with 5.55 mM glucose supplemented
with 0.4 µM calcium ionophore A23187. Controls were cultivated in DMEM
with 5.55 mM glucose. Shown are relative values in % of control as means±SD
of 8–9 experiments. (B) Glycogen content of C2C12 myotubes cultivated for
2 days in DMEM with lowered glucose (5.5 mM Glucose) or in DMEM with
25mMglucose supplemented with 0.1 µM calcium ionophore A23187. Controls
were cultivated in DMEM with 25 mM glucose. Shown are relative values in %
of control as means±SDof 3 experiments. ⁎ = significantly different compared to
controls, pb0.05, # = significantly different compared to muscle cells in DMEM
without glucose (−Glu.) in Fig. 3A and compared to C2C12myotubes in DMEM
with lowered glucose (5.5 mM Glucose) in Fig. 3B, pb0.05.genesis and MAT as a key enzyme for ketone body metabolism
[31–33].
As can be seen in Fig. 4A, 3 days in glucose-free DMEM or
application of 0.4 µM calcium ionophore A23187 both reduce
the specific GAPDH activity in adult myotubes to approxi-
mately 80% of control levels. The enzyme activity of CS shows
a significant increase of 20% after 3 days of glucose withdrawal
and an increase of more than 50% after elevation of intracellular
calcium concentration by A23187 treatment (Fig. 4B). Con-
sistent with the results for GAPDH enzyme activity, we find that
glucose-free conditions and calcium ionophore application
decrease GAPDH mRNA content to a similar degree (Fig. 4C).
PGC-1α expression is markedly elevated in the absence of
extracellular glucose, and treatment of the myotubes with cal-
cium ionophore results in an even more pronounced increase
(Fig. 4D). These findings show that expression of the two
markers of oxidative metabolism CS and PGC-1α is strongly
dependent on intracellular calcium concentration but can also be
increased by reduction of glucose supply. Also, expression of
GAPDH, the marker of anaerobic glycolysis, is equally affected
by calcium ionophore treatment and by removal of extracellular
glucose.
To further confirm these findings, we measured promoter
activities of GAPDH and MAT in C2C12 muscle cells by the
use of luciferase assays. C2C12 cells are usually cultivated in
DMEM containing 25 mM glucose. To reduce the glycogen
content of C2C12 cells, they were incubated in DMEM with
5.55 mM glucose (see Fig. 3B). Calcium ionophore treatment
was carried out with 0.1 µM A23187, instead of 0.4 µM as in
primary cultures, as required to maintain vitality of the trans-
fected C2C12 cells. Fig. 5 shows that reduction of glucose
supply and elevation of intracellular calcium concentration both
drastically decrease the activity of the GAPDH promoter and
increase that of the MAT promoter.
3.3. Phosphorylation status of AMPK, PKB/Akt andGSK-3 after
low glucose conditions, calcium ionophore or GPA treatment
To investigate the participation of AMP-activated protein
kinase (AMPK), protein kinase B (PKB/Akt) and glycogen
synthase kinase-3 (GSK-3) in the regulation of the observed
metabolic adaptation, we analysed the phosphorylation status of
these kinases by Western Blotting experiments with phospho-
peptide specific antibodies after exposure of adult myotubes to
low glucose conditions, calcium ionophore A23187 or 3-gua-
nidinopropionic acid. AMPK is thought to be responsible for
upregulation of mitochondrial enzyme gene transcription [12]
whereas PKB and GSK-3 are involved in insulin- and growth
factor dependent glycogen synthesis and general translation
[34,35].
Fig. 6A shows that incubation in DMEM without glucose
results in dephosphorylation of AMPKα(Thr172), PKB(Thr308)
and GSK-3β(Ser9). Dephosphorylation of AMPKα(Thr172)
and PKB(Thr308) decreases their protein kinase activities,
whereas dephosphorylated GSK-3β(Ser9) represents the acti-
vated form of the enzyme. Quantification of Western Blots
probed with antibodies against the phosphorylated forms of
Fig. 4. Incubation of adult skeletal muscle cells in DMEM without glucose or administration of 0.4 µM calcium ionophore for 3 days both lead to changes in enzyme
activities of GAPDH (A) and CS (B) as well as in GAPDH (C) and PGC-1α (D) gene expression. Shown are relative values in % of controls as means±SD of 6–9
experiments. ⁎ = significantly different from controls, pb0.05, # = significantly different from muscle cells in DMEM without glucose (−Glu.), pb0.05.
Fig. 5. Activities of GAPDH (A) and MAT promoters (B) in C2C12 muscle cells cultivated for 2 days in DMEM with lowered glucose (5.5 mM) or in DMEM with
25 mM glucose supplemented with 0.1 µM calcium ionophore A23187. Controls were cultivated in DMEM with 25 mM glucose. Shown are means±SD of 3
experiments. ⁎ = significantly different from controls, pb0.05.
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Fig. 6. Representative Western Blotting experiments with antibodies against phospho-AMPKα(Thr172), phospho-PKB(Thr308) and phospho-GSK-3β(Ser9).
(A) and (C) Western Blots of adult myotubes after 3 days of incubation in DMEM without glucose (−Glu.) or in DMEM with 5.55 mM glucose supplemented with
0.4 µM calcium ionophore A23187. Each treatment is shown in triplicate. (B) Quantification of Western Blots of adult myotubes treated for 3 days in DMEM with
5.55 mM (Control) or without glucose (−Glu.) probed with antibodies against phospho-AMPK, phospho-PKB and phospho-GSK-3, as well as with phospho-
unspecific antibodies to assess total amounts of AMPK, PKB and GSK-3. Shown are band density area products in % of controls as means±SD of 6–8 experiments.
⁎ = significantly different from corresponding controls, pb0.05. (D) lysates of myotubes that had been deprived of glucose for 0 min, 10 min, 30 min, 2 h or 24 h,
stained with anti-phospho-AMPK or anti-phospho-GSK-3. Each time-point is shown in duplicate. (E) Western Blots of myotubes after incubation in DMEM without
glucose (−Glu.) for one day with or without additional inhibition of glycogen turnover by the use of 0.2 mM 1,4-dideoxy-1,4-D-arabinitol (+DAB) and 0.5 mM N-
Butyldeoxynojirimycin (+BDN), see Fig. 8. Treatment with DAB and BDN started 16 h before the medium was changed to DMEM without glucose to ensure cell
permeation of the inhibitors. Each treatment is shown in duplicate.
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antibodies against these kinases is displayed in Fig. 6B. While
the decrease in phospho-AMPKunder low glucose ismatched by
a very similar decrease in total AMPK, the observed decreases in
phospho-PKB and phospho-GSK-3 are much more pronounced
than the decreases in total PKB and total GSK-3.
In contrast, 3 days of 0.4 µMcalcium ionophoreA23187 donot
change the phosphorylation of these kinases (Fig. 6C). Treatment
of skeletal muscle cells with 5 mM GPA for 3 days also has no
effect on phosphorylation status of AMPK (data not shown).
Fig. 6D depicts the time course of dephosphorylation of
AMPK and GSK-3 under low glucose conditions.
3.4. GAPDH and CS enzyme activities as functions of glycogen
content
Having seen that glucose deprivation leads to a reduction of
glycogen stores and to changes in the expression of the analysed
metabolic markers, we correlated the GAPDH and CS enzyme
activities of adult myotubes under different conditions to their
glycogen content (shown in Fig. 7), to see whether the expres-sion of GAPDH and CS exhibits a dependency on the glycogen
content of the muscle cells. Glycogen synthesis and degradation
are highly regulated and therefore the glycogen content of mus-
cle cells gives integrated information 1) about the rate of glucose
import by GLUT4 which via generation of G6P leads to allo-
steric activation of glycogen synthesis and 2) about increased
glycogenolytic rate, which can be effected by adrenergic stimu-
lation and elevated cytoplasmic calcium levels.
As can be seen in Fig. 7, relative GAPDH and CS enzyme
activities can be expressed as linear functions of relative glyco-
gen content. These correlations could indicate either that, in
addition to regulation by intracellular calcium, enzyme activi-
ties of GAPDH and CS can be influenced via glycogen content,
or that glycogen, GAPDH activity and CS activity react in
parallel to extracellular glucose supply.
3.5. Reduction of intracellular glycogen content as possible
trigger of metabolic adaptation
Intramuscular glycogen synthesis is stimulated not only in
response to insulin but also in response to glucose alone [36–38].
Fig. 7. Correlation of GAPDH enzyme activities and of CS enzyme activities to
corresponding glycogen contents of adult myotubes, respectively. Shown are
relative values in % of controls of myotubes incubated in DMEMwith 5.55 mM
glucose (○) or in DMEM without glucose (●). (A) GAPDH vs. glycogen:
n=53, R=0.796, pb0.001. (B) Citrate synthase vs. glycogen: n=43, R=0.766,
pb0.001.
Fig. 8. Glycogen content of adult myotubes cultivated for 3 days in DMEMwith
5.55 mM (white) or without glucose (grey) and treated with two different
inhibitors of glycogen degradation. Incubation with 0.2 mM 1,4-dideoxy-1,4-D-
arabinitol (+DAB) and 0.5 mM N-Butyldeoxynojirimycin (+BDN) started 16 h
before the medium was changed to DMEM without glucose (−Glu.) to ensure
cell permeation of the inhibitors. Shown are relative values in % of control as
means±SD of 3–9 experiments. ⁎ = significantly different compared to controls,
pb0.05. Degradation of glycogen in DMEM without glucose compared to
controls was only prevented when both inhibitors, DAB and BDN, were present.
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cause high intracellular glycogen contents and low extracellular
glucose concentrations lead, with a delay of approximately 2 h, to
a reduction of skeletal muscle glycogen stores [36,39] and own
observations. Because of the close relationship of these two
parameters it is difficult to differentiate if reduced glycogen con-
tent is the effective trigger of the observed metabolic adaptation.
On the one hand, there seems to be a correlation between glycogen
content and GAPDH or CS enzyme activities of the myotubes, as
shown in Fig. 7. On the other hand it is possible that glycogen
content and enzyme activities react in parallel to the extracellular
glucose concentration, so that the correlation in Fig. 7 might not
emanate from a direct dependence of the diagrammed variables.
To differentiate whether the effects of low glucose supply are
sensed via alterations in intracellular glycogen stores or not, we
uncoupled glycogen content and extracellular glucose supply by
using 1,4-dideoxy-1,4-D-arabinitol (DAB) and N-Butyldeoxy-
nojirimycin (BDN), two inhibitors of glycogen degradation, and
analysed the metabolic markers of myotubes with high glyco-
gen content at low extracellular glucose concentrations. DABinhibits the action of glycogen phosphorylase a (phosphorylated
active form), whereas BDN inhibits the lysosomal α-glucosi-
dases I and II. The skeletal muscle cells that received inhibitor
treatment were preincubated with the inhibitors to ensure cell
permeation of DAB and/or BDN before the exposure to medium
without glucose started. Fig. 8 gives the results of the glycogen
assays of adult myotubes treated with these two inhibitors of
glycogen degradation under high or low glucose conditions.
Administration of DAB (0.2 mM) or BDN (0.5 mM) alone
could not prevent the reduction of glycogen in medium without
glucose. Only combination of both of these inhibitors could avert
the utilization of glycogen when extracellular glucose supply
ceased. The fact that inhibition of glycogen phosphorylase alone
could not prevent glycogen breakdown inmediumwithout glucose
shows that glucosidases I and II contribute to glycogen degradation
in skeletal muscle. The importance of lysosomal α-glucosidases is
emphasized by comparing the consequences of the human genetic
defects of McArdle disease and Pompe disease. While the absence
of muscular glycogen phosphorylase in McArdle disease causes
only mild problems as long as the patient avoids demanding
physical strain, the lack of lysosomal α-glucosidase is the most
severe defect of glycogenmetabolism and causes early death of the
patients usually before their second birthday.
However, as shown in Fig. 9A, the GAPDH enzyme activity
under low glucose conditions was reduced compared to controls
independent of inhibitor treatment and of the glycogen content of
the cells (Fig. 8). The CS enzyme activity in medium without
glucose was increased in cells that had no inhibitor treatment as
well as in cells treated with DAB or DAB plus BDN, when
compared to the CS activity in cells in 5.55 mM extracellular
glucose (Fig. 9B), no matter whether the glycogen stores of these
myotubes were below or above control level (Fig. 8). Consistent
with the results of GAPDH enzyme activity, the GAPDH mRNA
levels in myotubes incubated with DAB plus BDN in the absence
Fig. 9. Enzyme activities of GAPDH (A) and CS (B) as well as semiquantitative RT-PCR results for GAPDH (C) and PGC-1α (D) of adult skeletal myotubes treated
with inhibitors of glycogen degradation DAB (+DAB) and BDN (+BDN), during incubation in DMEMwith or without glucose (−Glu.) for 3 days. Shown are relative
values in % of controls as means±SD of 3–9 experiments. ⁎ = significantly different from controls, pb0.05. There were no statistical differences found between the
groups of cells cultivated in DMEM with 5.55 mM glucose (white), nor were there differences between the groups cultivated in DMEM without glucose (grey).
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with medium without glucose (Fig. 9C). Furthermore, the PGC-
1αmRNA levels in cells that had no extracellular glucose supply
were the same, no matter whether these cells had high or low
glycogen content (Fig. 9D). Taken together, the alterations of the
measured metabolic markers, lowered expression of GAPDH
and elevated expression of markers of oxidative capacity, in
medium without glucose apparently are not suppressed by inhi-
bition of glycogen degradation.
In preliminary Western Blotting experiments (n=3) inhibi-
tion of glycogen degradation with DAB and BDN also showed
no effect on phosphorylation state of GSK-3 under low glucose
conditions. As shown in Fig. 6E phosphorylation of GSK-3 is
low after treatment with medium without glucose and could not
be elevated by preincubation with and addition of DAB and
BDN to glucose-free DMEM.
4. Discussion
Skeletal muscle adapts to endurance exercise, such as pro-
longed running or swimming, with a fast-to-slow transforma-tion that includes a decrease in glycolytic capacity and an
increase in mitochondrial density and oxidative capacity
[40–44]. Upregulation of mitochondrial metabolic enzymes
can be induced by elevated intracellular calcium and by
increased AMP concentrations [5,10–13,45]. Changes in the
concentrations of these second messengers are transmitted
via protein phosphatases and protein kinases like calcineu-
rin, CaMK I–IV and AMPK and lead to alterations in the
expression levels of genes like PGC-1α, CS, cytochrome c,
myoglobin and others [42,46,47]. Because contractile acti-
vity causes numerous perturbations of intracellular home-
ostasis, there might be further signals in addition to Ca2+
and AMP that contribute to the exercise-induced increase in
mitochondria, like changes in the concentration of glycolytic
intermediates, glycogen content, free fatty acids, ATP, NAD+/
NADH, pO2, pH, redox state or free radical production
[42,48]. In the present study, we investigated the possible
contributions of a reduction of intracellular ATP concentra-
tion and of a decrease in muscle glycogen content as potential
triggers of metabolic transformation of adult skeletal muscle
cells in culture.
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intracellular ATP concentration
Reduction of the intracellular ATP concentration of adult
myotubes in primary culture by treatment with GPA does not
induce alterations in the examined glycolytic and mitochondrial
markers, contrary to 3 days' incubation with calcium ionophore
A23187 (Fig. 2 and 4). So we reason that reduction of the ATP
content and subsequent increase of the AMP concentration in
the muscle cells by incubation with a creatine analogue do not
trigger metabolic transformation in rabbit-derived skeletal mus-
cle cells in primary culture.
4.2. Low glucose supply induces metabolic transformation in
cultured skeletal muscle cells
Absence of glucose in the extracellular medium or treatment
with calcium ionophore A23187 for 3 days both lead to a
reduction of the cellular glycogen store by approximately 50%
(Fig. 3A). This decrease is similar to observations in human
muscle by other groups, who found that incubation of human
myoblasts in the absence of glucose for 6 h leads to a reduction
of glycogen content by ~50% as well [36]. In vivo, 60 min of
cycling exercise of untrained healthy male volunteers at 62% of
VO2max even resulted in a glycogen depletion by 73% [49].
In addition to reducing glycogen content, lowered glucose
concentrations in the cell culture medium cause decreases in
GAPDH enzyme activity, GAPDH mRNA content (Fig. 4) and
GAPDH promoter activity (Fig. 5), as well as increases in CS
enzyme activity, PGC-1α transcripts (Fig. 4) and mitochondrial
acetoacetyl-CoA thiolase (MAT) promoter activity (Fig. 5) in
adult skeletal myotubes or C2C12 cells, respectively. In the
literature, there are several reports of in vivo-studies showing
that fasting or reduced carbohydrate ingestion lead within hours
to increased expression of PGC-1α, lipoprotein lipase (LPL),
uncoupling protein 3 (UCP3), mitochondrial thioesterase I
(MTE I), carnitine palmitoyltransferase I (CPT I) and pyruvate
dehydrogenase kinase 4 (PDK4) in skeletal muscle [50–53]. De
Lange et al. [51,53] in the fasting rat even report a skeletal
muscle fast-to-slow transformation at the level of myosin heavy
chains. Muscle-PDK4 is a negative regulator of glucose oxi-
dation and its expression can be induced by PGC-1α via elevated
expression and coactivation of the estrogen-related receptor α
(ERRα) [54]. In cardiac muscle PGC-1α expression is increased
in response to short-term fasting [55], while in liver fasting/
caloric restriction is reported to induce expression of PGC-1α,
ERRα, PPARα and CS [30,56].
The results presented in this paper demonstrate for the first
time that reduction of glucose supply in a muscle cell culture
leads to a coordinated decrease in expression of GAPDH and
increase in expression of several markers of oxidative meta-
bolism. Induction of mitochondrial metabolic enzymes under
low glucose conditions enables the myotubes to switch to oxi-
dative metabolism when the substrate for glycolytic/anaerobic
energy production is not available or greatly reduced.
The observed adaptation is qualitatively identical to the changes
in metabolic enzyme expression observed during fast-to-slowtransformation of skeletal muscle in vivo after endurance exercise
or chronic electrostimulation [43,44].
4.3. Phosphorylation of AMPK is neither enhanced by GPA
treatment nor by exposure to calcium ionophore nor by low
glucose conditions
So far, metabolic adaptation of skeletal muscle by initiation of
mitochondrial biogenesis is thought to be induced via an increase
inAMPconcentration that activatesAMPKand/or via an increase
in cytosolic Ca2+ leading to activation of CaMK and calcineurin
[10–13,57]. Concerning AMPK there also is evidence of a cor-
relation between reduction of muscle glycogen content and an
increase of AMPK activity [58] and, conversely, of an inhibitory
action of high glycogen content on AMPK activation [59–62].
Having seen that reduction of the cytoplasmic ATP con-
centration does not elicit changes in the measured metabolic
markers, we investigated the phosphorylation status of AMPK
after GPA treatment, after elevation of cytosolic calcium levels by
A23187 treatment and after incubation of the myotubes in me-
dium without glucose. In Western Blotting experiments we find
that GPA and calcium ionophore treatment induce no changes in
the phosphorylation state of AMPK (data not shown and Fig. 6C,
respectively), whereas incubation of cells in medium without
glucose and subsequent substantial reduction of glycogen stores
result in rapid dephosphorylation and therefore inactivation of
AMPK (Fig. 6A, B and D). This observation seems somewhat at
variancewith the in vivo observations of de Lange et al. [53], who
in the fasting rat find a rise in phospho-AMPK that is transient
with a peak at 6 h after start of food deprivation, and then returns to
the starting level, although myosin heavy chain Ib and UCP3
expression remain elevated. In contrast, we find a long-lasting fall
in phospho-AMPK after glucose withdrawal in vitro (Fig. 6A and
B). It should be noted that in vivo, as shown by de Lange et al.
[53], other factors than AMP levels decisively influence AMPK
activity, and in other species than the rat (mouse, human) the
increase in AMPK activity after fasting was not found [63].
The present observations lead to the conclusion that contrary
to expectations there is no activation of AMPK by AMPKK as a
consequence of GPA treatment. Furthermore, administration of
calcium ionophore or withdrawal of extracellular glucose do not
cause phosphorylation of AMPK in the adult myotubes, so that
this mechanism cannot be responsible for the metabolic trans-
formation of cultured muscle cells observed here in response to
calcium ionophore treatment or glucose deprivation. However,
while ionophore and GPA treatment leave AMPK phosphoryla-
tion unaffected, glucose withdrawal markedly decreases AMPK
phosphorylation, suggesting that different signalling cascades
are responsible for transformation by ionophore and by lowered
glucose, but neither one appears to be mediated by the es-
tablished mechanism of AMPK activation.
4.4. Lowglucose supply causes dephosphorylation andactivation of
GSK-3β— an effect similar to that observed after a bout of exercise
Whilst dephosphorylation of PKB/Akt causes deactivation
of PKB, the dephosphorylation of GSK-3β seen in Fig. 6A
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vations of decreased phosphorylation of PKB/Akt and GSK-3β
after glucose deprivation, Kim et al. report decreased activity
levels of PKB and increased GSK-3β activity in muscle of
muscle-specific GLUT4 glucose transporter knockout mice [64].
Once dephosphorylated, the active kinase GSK-3β is sup-
posed to inhibit glycogen synthase (GS) by phosphorylation
leading to cessation of glycogen synthesis and a lowered intra-
cellular glycogen content. In addition to inhibition of GS, GSK-
3β is able to phosphorylate various transcription factors like
GATA binding protein 4, cAMP response element binding pro-
tein or nuclear factor of activated T-cells 2 [35,65].
There exist microarray and real-time PCR data indicating that
GSK-3β gene expression is increased in human skeletal muscle
3 h after an exhaustive bout of endurance exercise [66]. This
increase in GSK-3β expression might play a role in altered
transcription factor regulation rather than in inhibition of glyco-
gen synthesis, because in the recovery time after exercise glyco-
gen synthesis normally is increased to replenish the glycogen
stores. Given that an increase of GSK-3β activity occurs under
low glucose conditions as well as after endurance exercise, it is
possible that GSK-3β activation is part of a shared signal trans-
duction pathway leading from endurance exercise as well as from
low glucose availability to metabolic transformation of skeletal
muscle cells.
4.5. Inhibition of glycogen breakdown does not prevent metabolic
adaptation to low glucose conditions
Even though we observed correlations between glycogen
content and GAPDH or CS enzyme activities respectively
(Fig. 7), the experiments with inhibitors of glycogen degrada-
tion 1,4-dideoxy-1,4-D-arabinitol (DAB) and N-Butyldeoxyno-
jirimycin (BDN) show that a high glycogen content at low
extracellular glucose concentration is not able to prevent the
adaptation of the studied metabolic enzymes, suggesting that a
decrease of glycogen content or an increase of the glycogen-
derived metabolite glucose-1-phosphate are not responsible for
the observed metabolic alterations.
Having abandoned the hypothesis of glycogen breakdown
per se generating a signal for the induction of metabolic adap-
tation, we suggest that the changes in extracellular glucose
concentration that lead to adaptation of metabolic enzyme
expression in the cell culture might be sensed via alterations in
concentrations of intracellular glucose metabolites. As con-
tractile activity, which is the physiological stimulus for fast-to-
slow transformation during endurance training, also causes
changes in glycolytic intermediates [49,67,68], altered con-
centration of a glucose-derived metabolite (like, e.g., glucose-
6-phosphate) could be a suitable signal indicating a need for
metabolic adaptation.
Concerning metabolites that are able to influence the expres-
sion of metabolic genes, it has been reported in liver that high
extracellular glucose concentrations result in the induction of
glycolytic and lipogenic genes, independently of insulin signal-
ling [69,70]. The effect of glucose on glycolytic and lipogenic
gene expression requires phosphorylation of glucose to G6P byhepatic glucokinase and is probably transduced via the pentose
phosphate pathway metabolite xylulose-5-phosphate (X5P),
which mediates the activation of protein phosphatase 2a. This
activation leads to dephosphorylation and nuclear translocation
of a transcription factor called “carbohydrate responsive element
binding protein” (ChREBP), which stimulates the transcription
of genes like liver pyruvate kinase, fatty acid synthase or acetyl-
CoA carboxylase [71,72]. Since high glucose conditions sti-
mulate glycolysis and synthesis of fatty acids via X5P in liver, it
may be expected that low glucose availability leads to reduction
of glycolytic throughput and increased oxidation of fatty acids.
This or a similar mechanism might work in skeletal muscle as
well, which remains to be investigated.
5. Conclusions
The results presented here demonstrate that metabolic adap-
tation of skeletal muscle cells from rabbit can be induced not
only by elevation of the intracellular calcium concentration but
also by reduction of extracellular glucose supply. Contrary to
expectations we show that neither ATP depletion nor reduction
of muscular glycogen content are crucial events in the induc-
tion of metabolic transformation in the primary muscle cell
culture. How exactly low extracellular glucose concentration,
which leads to decreased expression of GAPDH and increased
expression of PGC-1α, CS and MAT, is sensed by the muscle
cells and how this signal is transduced remains to be eluci-
dated. As glycogen breakdown can now be ruled out as sig-
nalling event for metabolic transformation, we speculate that
low glucose supply might be sensed via alterations in the con-
centration of a glucose-derived metabolite, perhaps analogous
to the X5P mechanism described under high glucose condi-
tions in liver.
Regarding the signal transduction leading from low glucose
availability to metabolic adaptation there is evidence to suggest
a participation of GSK-3β, which is activated via dephosphory-
lation under low glucose conditions.
Since physiological situations involving energy deprivation
in skeletal muscle include exercise and fasting [63], it may be
a plausible hypothesis that during these situations alterations
in glucose metabolites occur, reflecting insufficient GLUT4-
mediated glucose import, that are mimicked by glucose depri-
vation in the present primary skeletal muscle cell culture. Thus,
the metabolic transformation observed here under low glucose
conditions may be effected by a mechanism that is also operative
during exercise-induced muscle transformation or in response to
food deprivation. In all these situations it is physiologically
beneficial to switch metabolism from anaerobic glycolysis to
oxidative pathways.
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